TABLE 2.

KIM-1 and NGAL mRNA levels (arbitrary units) in BUO, B-R1D, and B-R3D kidney with or without aliskiren treatment.

	KIM-1	NGAL
Sham	1 ± 0.3	1 ± 0.3
BUO	446 ± 45.2∗	167 ± 51.5∗
BUO + Ali	236 ± 3.2∗#	152 ± 10.6∗
Sham	1 ± 0.1	1 ± 0.2
B-R1D	152 ± 6.9∗	112 ± 21.4∗
B-R1D + Ali	125 ± 13.4∗	34.5 ± 5.8∗#
Sham	1 ± 0.2	1 ± 0.2
B-R3D	19.4 ± 2.6∗	16.6 ± 3.9∗
B-R3D + Ali	18.9 ± 1.6∗	15.3 ± 1.4∗

KIM-1, kidney injury molecule-1; NGAL, neutrophil gelatinase-associated lipocalin; Sham, sham-operated groups; BUO, bilateral ureteral obstruction for 24 h; B-R1D, bilateral ureteral obstruction for 16 h followed by 1 day release; B-R3D, bilateral ureteral obstruction for 16 h followed by 3 days release. ^∗p < 0.05 compared with Sham group; ^#p < 0.05 compared with obstructed kidney group.